A recent study found specifically decreased CD62L in correlation with breast cancer metastasis, indicating those neutrophils may be tumor promotive [50], and CD62Llo neutrophils benefited metastatic spread in melanoma models [51], hence warranting further evaluation if a similar mechanism is in NEN as well. This evidence concerns the gene SELL and breast cancer.